Association of Life's Simple 7 with incident dementia and its modification by the apolipoprotein E genotype

INTRODUCTION There is limited and inconsistent reporting on the association between Life's Simple 7 (LS7) and dementia in the elderly population. METHODS Based on the Washington Heights-Inwood Columbia Aging Project (WHICAP), LS7 scores were estimated to assess cardiovascular health status. Associations between LS7 scores and incident dementia were investigated by Cox proportional hazards models. RESULTS Among 1987 subjects, 291 incident cases of dementia were identified over a median follow-up of 5.84 years. Compared with subjects in the poor cardiovascular health group (scores 0 to 5), those in intermediate (6 to 9) and optimal (10 to 14) groups had lower dementia risk, with the hazard ratio (HR; 95% confidence interval) being 0.74 (0.54 to 1.00) and 0.59 (0.38 to 0.91), respectively. These results were significant in apolipoprotein E genotype ε4 (APOE ε4) allele non-carriers but not in carriers. DISCUSSION Higher LS7 scores are protective for dementia, especially among the APOE ε4 noncarriers.

[1]  A. Brickman,et al.  Assessment of Leisure Time Physical Activity and Brain Health in a Multiethnic Cohort of Older Adults , 2020, JAMA network open.

[2]  D. Bennett,et al.  Author response: Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies , 2020 .

[3]  D. Bennett,et al.  Healthy lifestyle and the risk of Alzheimer dementia , 2020, Neurology.

[4]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[5]  R. Mayeux,et al.  Current and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults , 2019, Alzheimer's & Dementia.

[6]  M. Carrillo,et al.  World-wide fingers network: A global approach to risk reduction and prevention of dementia , 2019, Journal of the Neurological Sciences.

[7]  G. Bu,et al.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies , 2019, Nature Reviews Neurology.

[8]  T. Littlejohns,et al.  Association of Lifestyle and Genetic Risk With Incidence of Dementia. , 2019, JAMA.

[9]  Klaus P. Ebmeier,et al.  Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study , 2019, BMJ.

[10]  M. Ikram,et al.  Genetic predisposition, modifiable risk factor profile and long-term dementia risk in the general population , 2019, Nature Medicine.

[11]  G. Waldemar,et al.  Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise , 2019, Alzheimer's & dementia.

[12]  Miia Kivipelto,et al.  Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease , 2018, Nature Reviews Neurology.

[13]  Cécile Proust-Lima,et al.  Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia , 2018, JAMA.

[14]  D. Melzer,et al.  Impact of Low Cardiovascular Risk Profiles on Geriatric Outcomes: Evidence From 421,000 Participants in Two Cohorts , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  D. Knopman,et al.  Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results , 2018, Alzheimer's & Dementia.

[16]  H. Soininen,et al.  Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial , 2018, JAMA neurology.

[17]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[18]  A. Villringer,et al.  APOE e4-Genotype and Lifestyle Interaction on Cognitive Performance: Results of the LIFE-Adult-Study , 2017, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[19]  R. Ramírez-Campillo,et al.  Relationship Between Ideal Cardiovascular Health and Disability in Older Adults: The Chilean National Health Survey (2009–10) , 2017, Journal of the American Geriatrics Society.

[20]  K. Sink,et al.  Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis , 2017, Alzheimer's & dementia.

[21]  C. DeCarli,et al.  Relation of Dysglycemia to Structural Brain Changes in a Multiethnic Elderly Cohort , 2017, Journal of the American Geriatrics Society.

[22]  Edo Richard,et al.  Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial , 2016, The Lancet.

[23]  Hans Förstl,et al.  Predicting dementia in primary care patients with a cardiovascular health metric: a prospective population-based study , 2016, BMC Neurology.

[24]  Danielle M. Enserro,et al.  Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia , 2016, Stroke.

[25]  Sterling C. Johnson,et al.  Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes , 2016, Diabetes Care.

[26]  R. Sacco,et al.  Ideal Cardiovascular Health and Cognitive Aging in the Northern Manhattan Study , 2016, Journal of the American Heart Association.

[27]  M. Weiner,et al.  Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders. , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[28]  M. Viitanen,et al.  Insulin resistance is associated with poorer verbal fluency performance in women , 2015, Diabetologia.

[29]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[30]  Karen Bandeen-Roche,et al.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. , 2014, JAMA neurology.

[31]  S. Haneuse,et al.  Glucose levels and risk of dementia. , 2013, The New England journal of medicine.

[32]  L. Launer,et al.  Lifestyle and the Risk of Dementia in Japanese‐American Men , 2012, Journal of the American Geriatrics Society.

[33]  P. Barberger‐Gateau,et al.  Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. , 2011, Current Alzheimer research.

[34]  S. Kanba,et al.  Midlife and Late-Life Blood Pressure and Dementia in Japanese Elderly: The Hisayama Study , 2011, Hypertension.

[35]  H. Soininen,et al.  Midlife Smoking, Apolipoprotein E and Risk of Dementia and Alzheimer’s Disease: A Population-Based Cardiovascular Risk Factors, Aging and Dementia Study , 2010, Dementia and Geriatric Cognitive Disorders.

[36]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[37]  B. Lawlor,et al.  Blood pressure and the risk for dementia—A double edged sword , 2009, Ageing Research Reviews.

[38]  B. Winblad,et al.  Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study , 2008, Journal of cellular and molecular medicine.

[39]  R. Mayeux,et al.  Effect of smoking and time on cognitive function in the elderly without dementia , 2005, Neurology.

[40]  R. Mayeux,et al.  The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function , 2002, Neurology.

[41]  M. Irwin,et al.  Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D) , 1999, Archives of internal medicine.

[42]  G. Schellenberg,et al.  The Effect of Apolipoprotein E ε4 in the Relationships of Smoking and Drinking to Cognitive Function , 1999, Neuroepidemiology.

[43]  R. Mayeux,et al.  The influence of smoking on the risk of Alzheimer’s disease , 1999, Neurology.

[44]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[45]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[46]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[47]  C. Bell.  DSM-IV: Diagnostic and Statistical Manual of Mental Disorders , 1994 .

[48]  R. Mayeux,et al.  Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. , 1992, Archives of neurology.

[49]  L. Montoliu-Gaya,et al.  The Role of Apolipoprotein E Isoforms in Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.

[50]  D. Llewellyn,et al.  Physical Activity, APOE Genotype, and Cognitive Decline: Exploring Gene-Environment Interactions in the UK Biobank. , 2019, Journal of Alzheimer's disease : JAD.

[51]  S. Jaber,et al.  Glucose Levels and Risk of Dementia , 2013 .

[52]  G. Schellenberg,et al.  The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function. , 1999, Neuroepidemiology.